Back to Search
Start Over
Fibrinolysis shutdown phenotype masks changes in rodent coagulation in tissue injury versus hemorrhagic shock
- Source :
- Surgery. 158:386-392
- Publication Year :
- 2015
- Publisher :
- Elsevier BV, 2015.
-
Abstract
- Introduction Systemic hyperfibrinolysis (accelerated clot degradation) and fibrinolysis shutdown (impaired clot degradation) are associated with increased mortality compared with physiologic fibrinolysis after trauma. Animal models have not reproduced these changes. We hypothesize rodents have a shutdown phenotype that require an exogenous profibrinolytic to differentiate mechanisms that promote or inhibit fibrinolysis. Methods Fibrinolysis resistance was assessed by thrombelastography (TEG) using exogenous tissue plasminogen activator (tPA) titrations in whole blood. There were 3 experimental groups: (1) tissue injury (laparotomy/bowel crush), (2) shock (hemorrhage to mean arterial pressure of 20 mmHg), and (3) control (arterial cannulation and tracheostomy). Baseline and 30-minute postintervention blood samples were collected, and assayed with TEG challenged with taurocholic acid (TUCA). Results Rats were resistant to exogenous tPA; the percent clot remaining 30 minutes after maximum amplitude (CL30) at 150 ng/mL ( P = .511) and 300 ng/mL ( P = .931) was similar to baseline, whereas 600 ng/mL ( P = .046) provoked fibrinolysis. Using the TUCA challenge, the percent change in CL30 from baseline was increased in tissue injury compared with control ( P = .048.), whereas CL30 decreased in shock versus control ( P = .048). tPA increased in the shock group compared with tissue injury ( P = .009) and control ( P = .012). Conclusion Rats have an innate fibrinolysis shutdown phenotype. The TEG TUCA challenge is capable of differentiating changes in clot stability with rats undergoing different procedures. Tissue injury inhibits fibrinolysis, whereas shock promotes tPA-mediated fibrinolysis.
- Subjects :
- Male
Taurocholic Acid
medicine.medical_specialty
Mean arterial pressure
medicine.medical_treatment
Abdominal Injuries
Shock, Hemorrhagic
Tissue plasminogen activator
Article
Rats, Sprague-Dawley
Random Allocation
chemistry.chemical_compound
Fibrinolytic Agents
Internal medicine
Fibrinolysis
medicine
Animals
Whole blood
business.industry
medicine.disease
Taurocholic acid
Hyperfibrinolysis
Rats
Thrombelastography
Disease Models, Animal
Phenotype
Endocrinology
chemistry
Coagulation
Tissue Plasminogen Activator
Anesthesia
Shock (circulatory)
Surgery
medicine.symptom
business
medicine.drug
Subjects
Details
- ISSN :
- 00396060
- Volume :
- 158
- Database :
- OpenAIRE
- Journal :
- Surgery
- Accession number :
- edsair.doi.dedup.....c8ce16efbf7b018d2f93c14ccad2c45c
- Full Text :
- https://doi.org/10.1016/j.surg.2015.04.008